Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 0.18 ▼ -0.01 (-5.31%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0543 | -22.22% | 0.1901 | 0.245 | 0.19 | 0.245 | 0.2444 | 23:59:42 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.176 | 0.32 | 0.144 | 45.0% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,564 | 1,561,508 | $ 0.2031367 | $ 317,200 | 296,868 | 0.19 - 0.54 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:12:06 | formt | 7,522 | $ 0.18 | USD |
Phio Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 4.86M | 25.59M | $ -7.36M | -1.20 | - | 23.30M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -3.00 | 9.00% |
Phio Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.2336 | 0.33 | 0.19 | 0.287116 | 393,123 | -0.0435 | -18.62% |
| 1 Month | 0.2389 | 0.33 | 0.19 | 0.2556556 | 255,930 | -0.0488 | -20.43% |
| 3 Months | 0.34 | 0.41 | 0.19 | 0.2665641 | 204,722 | -0.1499 | -44.09% |
| 6 Months | 0.48 | 0.51 | 0.19 | 0.3441833 | 195,341 | -0.2899 | -60.4% |
| 1 Year | 0.39 | 0.54 | 0.19 | 0.3945907 | 375,337 | -0.1999 | -51.26% |
| 3 Years | 0.39 | 0.54 | 0.19 | 0.3945907 | 375,337 | -0.1999 | -51.26% |
| 5 Years | 0.39 | 0.54 | 0.19 | 0.3945907 | 375,337 | -0.1999 | -51.26% |
Phio Pharmaceuticals Description
| Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immunooncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The clinical development program of the company includes RXI-109, a sd-rxRNA for the treatment of dermal and ocular scarring, and Samcyprone, for the treatment of warts. The pipeline product of the company includes RXI-109, Immuno-oncology cell therapy, samcyprone, RXI-231, and RXI-185. The pipeline programs focus on dermatology, including cosmetic product development, ophthalmology, and cell-based cancer immunotherapy. |
